Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ichiro Sakuma

Showing results (241-250 of 257) with videos related to

Pageof 26
Sort By:
Science Advances|December 20, 2023
Single-shot optical imaging with spectrum circuit bridging timescales in high-speed photographyTakao Saiki, Keitaro Shimada, Ayumu Ishijima, et al.
Nature Communications|March 27, 2021
Cardiac macrophages prevent sudden death during heart stressJunichi Sugita, Katsuhito Fujiu, Yukiteru Nakayama, et al.
BMC Medicine|November 14, 2022
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular eventsMasashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 7, 2022
Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease　- Insights From the REAL-CAD StudyMasahiro Natsuaki, Takeshi Morimoto, Satoshi Iimuro, et al.
International Journal of Cardiology|February 13, 2018
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillationHiroaki Shimokawa, Takeshi Yamashita, Shinichiro Uchiyama, et al.
The Tohoku Journal of Experimental Medicine|December 2, 2016
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial FibrillationTakanori Ikeda, Hirotsugu Atarashi, Hiroshi Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 14, 2022
Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　- An Observation From the REAL-CAD StudyToshiaki Toyota, Takeshi Morimoto, Satoshi Iimuro, et al.
Journal of Clinical Lipidology|September 15, 2024
Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular diseaseKiyoshi Hibi, Masaomi Gohbara, Kohei Uemura, et al.
International Journal of Cardiology|June 24, 2023
Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery diseaseYoshiaki Mitsutake, Junnichi Ishii, Yoshihiro Fukumoto, et al.
American Heart Journal|June 26, 2021
Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudyMitsuru Abe, Yukio Ozaki, Hiroshi Takahashi, et al.
Pageof 26

Showing results (241-250 of 257) with videos related to

Sort By:
Pageof 26
Science Advances|December 20, 2023
Single-shot optical imaging with spectrum circuit bridging timescales in high-speed photographyTakao Saiki, Keitaro Shimada, Ayumu Ishijima, et al.
Nature Communications|March 27, 2021
Cardiac macrophages prevent sudden death during heart stressJunichi Sugita, Katsuhito Fujiu, Yukiteru Nakayama, et al.
BMC Medicine|November 14, 2022
Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular eventsMasashi Sakuma, Satoshi Iimuro, Tomohiro Shinozaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 7, 2022
Thrombotic Risk Stratification and Intensive Statin Therapy for Secondary Prevention of Coronary Artery Disease　- Insights From the REAL-CAD StudyMasahiro Natsuaki, Takeshi Morimoto, Satoshi Iimuro, et al.
International Journal of Cardiology|February 13, 2018
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillationHiroaki Shimokawa, Takeshi Yamashita, Shinichiro Uchiyama, et al.
The Tohoku Journal of Experimental Medicine|December 2, 2016
Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial FibrillationTakanori Ikeda, Hirotsugu Atarashi, Hiroshi Inoue, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 14, 2022
Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　- An Observation From the REAL-CAD StudyToshiaki Toyota, Takeshi Morimoto, Satoshi Iimuro, et al.
Journal of Clinical Lipidology|September 15, 2024
Serum mature and furin-cleaved proprotein convertase subtilisin/kexin type 9 levels and their association with cardiovascular events in statin-treated patients with cardiovascular diseaseKiyoshi Hibi, Masaomi Gohbara, Kohei Uemura, et al.
International Journal of Cardiology|June 24, 2023
Differential prediction of high-sensitivity cardiac troponin-I, but not N-terminal pro-brain natriuretic peptide, in different pitavastatin doses on cardiovascular events in stable coronary artery diseaseYoshiaki Mitsutake, Junnichi Ishii, Yoshihiro Fukumoto, et al.
American Heart Journal|June 26, 2021
Relation of renal function to mid-term prognosis of stable angina patients with high- or low-dose pitavastatin treatment: REAL-CAD substudyMitsuru Abe, Yukio Ozaki, Hiroshi Takahashi, et al.
Pageof 26